Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone

Parkinsonism Relat Disord. 2019 Jul:64:352-353. doi: 10.1016/j.parkreldis.2019.05.018. Epub 2019 May 11.

Authors

Alessio Novelli¹, Ilaria Antonella Di Vico², Federica Terenzi², Sandro Sorbi², Silvia Ramat²

Affiliations

¹ Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy. Electronic address: alessio.novelli@unifi.it.
² Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.

PMID: 31101554
DOI: 10.1016/j.parkreldis.2019.05.018

No abstract available

Keywords: Deep Brain Stimulation; Dyskinesia; Hyperkinetic emergencies; Hyperpyrexia; Parkinson's disease.

Publication types

Case Reports
Letter

MeSH terms

Antiparkinson Agents / administration & dosage
Antiparkinson Agents / adverse effects*
Carbidopa / administration & dosage
Carbidopa / adverse effects*
Catechols / administration & dosage
Catechols / adverse effects*
Combined Modality Therapy
Deep Brain Stimulation / adverse effects*
Drug Combinations
Drug Therapy, Combination
Fever / chemically induced
Fever / etiology*
Humans
Hyperkinesis / chemically induced
Hyperkinesis / etiology*
Levodopa / administration & dosage
Levodopa / adverse effects*
Male
Middle Aged
Nitriles / administration & dosage
Nitriles / adverse effects*
Parkinson Disease / drug therapy
Parkinson Disease / therapy*

Substances

Antiparkinson Agents
Catechols
Drug Combinations
Nitriles
carbidopa, levodopa drug combination
Levodopa
entacapone
Carbidopa